SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is a top trending stock following its earnings report, which, despite beating estimates, has been overshadowed by concerns regarding the Warner Bros Discovery acquisition. The community is sharply divided, with bulls viewing the current dip as an oversold opportunity for long-term content expansion, while bears cite the deal's cost, debt implications, and paused share buybacks as reasons for further downside. This strategic move and its perceived impact on future margins are driving intense discussion and significant price action.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network ($BNAI) is experiencing significant market attention following news of a strategic AI licensing partnership in Africa, including a pilot program with Nelson Mandela University. This development, combined with discussions around a reportedly thin float and high short interest, is driving substantial pre-market volatility and community speculation about a potential short squeeze. Traders are actively monitoring for sustained momentum, positioning BNAI as a key focus within the AI sector narrative.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical (DRTS) is trending with immense community excitement, primarily driven by the high anticipation of potential PMDA Japan approval for its Alpha DaRT therapy, following compelling pancreatic cancer data. Investors are increasingly bullish, viewing recent strong clinical updates and growing institutional interest as key catalysts for this innovative oncology technology, which many believe is poised for significant recognition.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending due to immediate market uncertainty surrounding an anticipated speech by Donald Trump at Davos, sparking community debate over potential tariffs and geopolitical tensions, particularly regarding Greenland. Sentiment is split, with some traders concerned about rising Japanese bond yields and broader market weakness, while others expect a rebound, highlighting underlying economic resilience and a potential rotation into small-cap and value stocks.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

SPDR Gold Shares ETF (GLD) is experiencing a parabolic rally to new record highs, driven by escalating global trade tensions and broad geopolitical uncertainty. The community is actively discussing gold's role as a safe haven amidst concerns over sovereign debt, potential currency debasement, and central bank diversification, fueling significant short-covering and strong bullish momentum.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is experiencing significant volatility and declines as natural gas futures surge dramatically, driven by widespread "Arctic Blast" weather forecasts across the US. This rapid price action is causing extreme pressure for many traders, leading to discussions of a "widowmaker" market as some cautiously "buy the dip" on KOLD while others are caught in the squeeze.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as President Trump's aggressive rhetoric regarding Greenland and potential new tariffs, coupled with concerns over Japan's bond market, fuels a broad market sell-off. The community is sharply divided, with many anticipating further declines and a retest of crucial support levels, while others expect an eventual 'buy the dip' recovery, viewing current fears as an overreaction.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to overwhelmingly positive Phase 1 clinical trial results for its atopic dermatitis drug, soquelitinib, demonstrating strong efficacy and a favorable safety profile even in treatment-resistant patients. This promising early data has ignited bullish sentiment about its blockbuster potential and possible short squeeze, despite community concerns surrounding a recently announced public offering to fund future trials.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending due to reports of exceptionally high-grade silver drill results across its vast land, significantly boosting optimism for future production. The community is actively discussing continuous insider buying by Eric Sprott and surging precious metal prices as catalysts for substantial upside, while also considering the company's non-producing status and potential for dilution. This confluence of factors, coupled with discussions of a possible short squeeze and growing silver demand, is driving intense conversation around the mining company.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility and intense discussion, largely influenced by President Trump's remarks at the Davos World Economic Forum and ongoing geopolitical tensions. The community remains deeply divided, with many bears highlighting significant drops and questioning Bitcoin's safe-haven status amidst rising gold prices, while bulls emphasize strong accumulation by institutional players and technical indicators pointing to a potential rebound from leveraged short attacks.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Southwest Airlines (LUV) Expected to Announce Earnings on Wednesday

Southwest Airlines (NYSE:LUV) will be releasing its Q4 2025 earnings after the market closes on Wednesday, January 28. (View Earnings Report at...

Southwest Airlines (NYSE:LUV) Stock Price Passes Above 200-Day Moving Average - Time to Sell?

Southwest Airlines (NYSE:LUV) Shares Pass Above Two Hundred Day Moving Average - Should You Sell...

Airlines have 580 million reasons to like GLP-1 weight-loss drugs, analysis finds

Airlines stand to save a potential $580 million as travelers slim down thanks to the effects of weight-loss drugs, a new study found.Sheila Kahyaoglu, an equity analyst at Jefferies and an author of...

Airline Stocks To Research - January 19th

American Airlines Group, Delta Air Lines, United Airlines, Joby Aviation, Southwest Airlines, Alaska Air Group, and JetBlue Airways are the seven Airline stocks to watch today, according to...

Airline Stocks To Watch Today - January 18th

Airline Stocks To Keep An Eye On - January 17th

Surging Earnings Estimates Signal Upside for Southwest (LUV) Stock

Southwest Airlines (LUV) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Lufthansa is latest to ban use of item many other airlines allow

Although restrictions on packing lithium-ion batteries, and the power banks that contain them, in checked luggage date back to 2016, airlines will often have different rules on how passengers should...

<ul class="summary-bullets"><li>According to a CNBC report, Jefferies said in a note to clients that a 10% reduction in average weight per passenger could result in about 2% weight savings per aircraft, in turn reducing fuel costs by up to 1.5%.&nbsp;</li><li>This could result in up to a 4% increase in earnings per share.</li><li>American Airlines, Delta Air Lines, United Airlines, and Southwest Airlines are touted to be among the largest beneficiaries, as per Jefferies.</li></ul>Wall Street analyst Jefferies believes America’s weight-loss obsession could benefit airline companies through lower fuel costs.According to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2026/01/14/airlines-to-save-on-fuel-as-weight-loss-pills-grow-popular-wall-street-says.html">report</a> in CNBC, Jefferies said in a note to clients that a 10% reduction in average weight per passenger could result in about 2% weight savings per aircraft, in turn reducing fuel costs by up to 1.5%. This could lead to up to a 4% increase in earnings per share, as per the analyst.Weight is a major determinant of fuel efficiency for aircraft since the higher the weight of a plane, the more fuel it burns. As GLP-1 weight-loss drugs become commercially available in pill form, Jefferies sees a broad adoption of these lowering fuel bills, a big chunk of operating expenses, for aircrafts.“A slimmer society = lower fuel consumption,” Jefferies reportedly said in the note, reaffirming a stance that it has taken before.American Airlines Group Inc. (AAL), Delta Air Lines, Inc. (DAL), United Airlines Holdings Inc. (UAL), and Southwest Airlines Co. (LUV) are touted to be among the largest beneficiaries from the weight-loss boom, as per Jefferies.<h2 class="st-heading-2">The Math</h2>The four largest U.S. airlines are collectively expected to use about 16 billion gallons of fuel in 2026, as per Jefferies. Estimating an average price of $2.41 a gallon, this would come up to nearly $39 billion for the year, the firm said.Jefferies said that assuming that a 1% reduction in aircraft weight could improve fuel efficiency by 0.75%, a 2% decline in weight per passenger on average could lead to about a 4% earnings upside per share for the airlines, with potential earnings per share (EPS) boost of about 2.8% for Delta Air Lines, 3.5% for United Airlines, 4.2% for Southwest Airlines, and up to 11.7% for American Airlines.In 2023, Jefferies released a broader analysis on the potential beneficiaries of&nbsp; Novo Nordisk’s (NVO) Ozempic drug use, noting how airlines were likely to benefit. The analyst outlined its case with an example of United Airlines at the time, citing it would save $80 million a year, assuming an average passenger weight loss of 10 pounds.<h2 class="st-heading-2">Weight-Loss Market</h2>The global weight-loss drug market is expanding rapidly. As per McKinsey, nearly one in three adults in the U.S. or roughly 100 million people, and another 900 million worldwide, meet the clinical criteria for obesity.Morgan Stanley <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.morganstanley.com/insights/articles/weight-loss-medication-market-unstoppable-growth">estimates</a> that roughly 11% of 1.3 billion people across the world could be on obesity drugs, translating to about 20% of eligible patients in the U.S. and 10% in other countries. At present, the adoption rate for weight-loss drugs is around 3% in the U.S. and 1% in other countries.As per Morgan Stanley, the market for these drugs could reach $150 billion by 2035, up from $15 billion in 2024, while IQVIA <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.iqvia.com/library/articles/obesity-market-revolution">projects</a> the market will reach $130 billion by 2034.At present, the market relies largely on injectable GLP-1 and GLP-1/GIP receptor agonists, which reduce appetite and improve metabolic control. Novo Nordisk leads with drugs like Wegovy, while Lilly has strengthened its position with Zepbound (tirzepatide).However, in December 2025, the Wegovy pill was <a href="https://stocktwits.com/news-articles/markets/equity/novo-nordisk-stock-soars-after-hours-as-fda-greenlights-wegovy-pill-for-weightloss/cLeFw1kREu2">greenlit</a> by the U.S. Food and Drug Administration, becoming the first FDA-approved oral GLP-1 class drug for weight management. Meanwhile, rival Eli Lilly (LLY), expects its oral obesity drug Orforglipron to be approved for commercial use early this year.Shares of DAL have gained about 2.5% in the past year while UAL stock gained nearly 3% in the same time and LUV shares have rallied over 27%. Meanwhile, shares of AAL have lost over 17% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Injections for weight loss with Semaglutide. An obese woman gives a hormone glucagon-like peptide-1 (GLP-1) injection into the abdomen with a pen syringe.

Slimmer Waistlines, Fatter Margins: Jefferies Says Airline Companies Will Profit From America’s Weight-Loss Boom

Jefferies sees a broad adoption of weight loss pills ultimately lowering fuel bills for aircrafts, in turn leading to higher earnings. 

Equity

Are Investors Undervaluing Southwest Airlines (LUV) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Southwest Airlines Co. engages in the operation and management of a passenger airline. The firm also offers ancillary services such as early bird check-in, upgraded boarding, and transportation of pets and unaccompanied minors. It operates in the United States, the Commonwealth of Puerto Rico, Mexico, Jamaica, the Bahamas, Aruba, Dominican Republic, Costa Rica, Belize, Cuba, the Cayman Islands, and Turks and Caicos. The company was founded by Rollin W. King and Herbert D. Kelleher on March 9, 1967 and is headquartered in Dallas, TX.

Southwest Airlines Co

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.57	--	--	N/A
Q3 '25	-$0.00	$0.11	3792.51%	BEAT
Q2 '25	$0.51	$0.43	-15.91%	MISSED
Q1 '25	-$0.18	-$0.13	29.18%	BEAT
Q4 '24	$0.46	$0.56	21.31%	BEAT

LUV
Southwest Airlines Co

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest LUV News

LUVSouthwest Airlines Co